Key facts
- This page summarizes William DeVaul's Form 4 filing for Morphic Holding, Inc..
- 3 reported transactions and 1 derivative row are listed below.
- Filing timestamp: 10 Jul 2024, 17:32.
William DeVaul - 08 Jul 2024 Form 4 Insider Report for Morphic Holding, Inc.
- Signature
- /s/ Robert Farrell, Attorney-in-Fact for William DeVaul
- Issuer symbol
- N/A
- Transactions as of
- 08 Jul 2024
- Net transactions value
- -$514,756
- Form type
- 4
- Filing time
- 10 Jul 2024, 17:32:17 UTC
- Previous filing
- 17 Jan 2024
- Next filing
- 07 Aug 2024
- SEC
- View on sec.gov
Key filing fact
William DeVaul filed Form 4 for Morphic Holding, Inc. on 10 Jul 2024.
Change
- Previous filing in this sequence was filed on 17 Jan 2024.
- Current net transaction value: -$514,756.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
MORF
transaction
Common Stock
Options Exercise
- Transaction value
- $43,151
- Shares
- +10,000
- Change %
- +43%
- Price
- $4.32
- Shares after
- 33,029
- Date
- 08 Jul 2024
- Ownership
- Direct
MORF
transaction
Common Stock
Sale
- Transaction value
- $557,907
- Shares
- -10,000
- Change %
- -30%
- Price
- $55.79
- Shares after
- 23,029
- Date
- 08 Jul 2024
- Ownership
- Direct
- Footnotes
- F1, F2
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
MORF
transaction
Derivative
Employee Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -10,000
- Change %
- -8.8%
- Price
- $0.000000
- Shares after
- 103,855
- Date
- 08 Jul 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,000
- Exercise price
- $4.32
- Footnotes
- F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 28, 2023. |
| F2 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.79 to $55.80 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | The option is fully vested. |